QA: Cartesian Therapeutics Inc. in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001453687_2022_Cartesian_Therapeutics_Inc.pdf

Logs

Graph

Absolute values for 0001453687, Cartesian Therapeutics Inc.

  xvar xval
0 AssetsCurrent 144,443,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 2,142,000
3 remainder_Assets 13,298,000
4 LiabilitiesCurrent 72,251,000
5 LiabilitiesNoncurrent 20,015,000
6 remainder_Liabilities 45,096,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 20,938,000
9 ResearchAndDevelopmentExpense 68,736,000
10 remainder_Expenses 21,149,000
11 remainder_Revenues 85,077,000
12 remainder_NetIncome 59,000
13 remainder_ComprehensiveNetIncome -3,000
  yvar yval
0 Assets 159,883,000
1 Liabilities 137,362,000
2 Expenses 110,823,000
3 Revenues 85,077,000
4 StockholdersEquity 22,521,000
5 NetIncome -25,687,000
6 ComprehensiveNetIncome -25,688,500
7 BaseVar 246,603,500
8 EconomicCapitalRatio 0.0878

Edgar->Model Mapping

Feature Distribution

Change over Time